Nelarabine-related rhabdomyolysis in a patient with T-cell acute lymphoblastic leukemia

Leuk Lymphoma. 2020 Nov;61(11):2775-2777. doi: 10.1080/10428194.2020.1791852. Epub 2020 Jul 11.

Authors

Ramesh Kumar Pandey¹, Adam DiPippo¹, Tapan Kadia¹, Naveen Pemmaraju¹, Biruh Tesfa Workeneh¹, Elias Jabbour¹, Farhad Ravandi¹, Nitin Jain¹

Affiliation

¹ The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

PMID: 32654562
DOI: 10.1080/10428194.2020.1791852

No abstract available

Publication types

Letter

MeSH terms

Arabinonucleosides / adverse effects
Humans
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / complications
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / diagnosis
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
Rhabdomyolysis* / chemically induced
Rhabdomyolysis* / diagnosis
T-Lymphocytes

Substances

Arabinonucleosides
nelarabine